Concepedia

Russell Vassell

RV

43

Publications

2.1K

Citations

25

H-Index

1994

Active since

Affiliations

Center for Biologics Evaluation and Research(Current)

United States Food and Drug Administration

National Institutes of Health

Henry M. Jackson Foundation

National Institute of Allergy and Infectious Diseases

Russell Vassell is an author at Center for Biologics Evaluation and Research specializing in medicine, immunology, and virology.

ORCID

Top concepts

Publications per year

1994–2023

43

Publications

43

Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge.

Gregory M. Glenn, Tanya Scharton‐Kersten, Russell Vassell et al. · PubMed · 1998 · 153 citations

, , +15

Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2

Sabari Nath Neerukonda, Russell Vassell, Rachel Herrup et al. · PLoS ONE · 2021 · 139 citations · Full text

, , +11

Peptides Trap the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Fusion Intermediate at Two Sites

Yong He, Russell Vassell, Marina Zaitseva et al. · Journal of Virology · 2003 · 138 citations · Full text

, , +15

Cutting Edge: Transcutaneous Immunization with Cholera Toxin Protects Mice Against Lethal Mucosal Toxin Challenge

Gregory M. Glenn, Tanya Scharton‐Kersten, Russell Vassell et al. · The Journal of Immunology · 1998 · 138 citations · Full text

, , +17

Transcutaneous Immunization with Bacterial ADP-Ribosylating Exotoxins as Antigens and Adjuvants

Gregory M. Glenn, Tanya Scharton‐Kersten, Russell Vassell et al. · Infection and Immunity · 1999 · 137 citations · Full text

Rows per page

1–5 of 43